Inari Medical, Inc. (NARI)
NASDAQ: NARI · Real-Time Price · USD
55.45
+1.04 (1.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
Inari Medical Employees
Inari Medical had 1,300 employees as of December 31, 2023. The number of employees increased by 200 or 18.18% compared to the previous year.
Employees
1,300
Change (1Y)
200
Growth (1Y)
18.18%
Revenue / Employee
$441,922
Profits / Employee
-$60,448
Market Cap
3.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,300 | 200 | 18.18% |
Dec 31, 2022 | 1,100 | 300 | 37.50% |
Dec 31, 2021 | 800 | 344 | 75.44% |
Dec 31, 2020 | 456 | 257 | 129.15% |
Dec 31, 2019 | 199 | - | - |
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Envista Holdings | 12,800 |
Oscar Health | 2,400 |
NovoCure | 1,453 |
Veracyte | 815 |
Denali Therapeutics | 445 |
Rhythm Pharmaceuticals | 226 |
Verona Pharma | 79 |
NARI News
- 3 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities Investigation - Accesswire
- 19 days ago - Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd. - GlobeNewsWire
- 19 days ago - Inari Medical Announces Joint Venture in Greater China - GlobeNewsWire
- 7 weeks ago - PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism - GlobeNewsWire
- 7 weeks ago - Inari Medical, Inc. (NARI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Inari Medical Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Okami Medical Announces Closing Of $32.5M Financing - PRNewsWire